Navigation Links
Prometheus Highlights Record Performance in 2010
Date:3/1/2011

e market-leading PROMETHEUS® IBD Serology 7. The Crohn's Prognostic test combines six serologic markers and three genetic mutation markers to provide physicians with a personalized serogenetic profile for their patients.  This test helps enable physicians to quantify these patients' risk of developing disease complications and is designed to provide information to assist physicians in determining optimal treatment strategies for their Crohn's patients.
  • In December, Prometheus extended its distribution agreement with AstraZeneca LP for the exclusive marketing, sales and distribution of ENTOCORT® EC (budesonide) Capsules in the United States the earlier of December 31, 2011 or 30 days after the sale of a generic equivalent in the United States.  Entocort EC is the only FDA-approved drug for the induction and maintenance of clinical remission in mild to moderate Crohn's disease involving the ileum and/or the ascending colon.  Entocort EC is indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon (up to 8 weeks with repeated 8-week courses as necessary for recurring episodes of active disease), and the maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months.  Clinical remission is defined as a Crohn's Disease Activity Index (CDAI) score of greater than or equal to 150.

  • Development Product Highlights

  • In March, Prometheus executed a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic CEER™ platform with certain compounds in Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products. Prometheus receiv
    '/>"/>

  • SOURCE Prometheus Laboratories Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
    2. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
    3. Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
    4. Prometheus Launches ProOnc Dx Cancer Diagnostics
    5. Prometheus Acquires Exclusive Rights to PROLEUKIN(R) (aldesleukin) in the U.S.
    6. Prometheus Announces New Method for Real-Time Monitoring of Patients Treated With Biologic Therapy
    7. Prometheus and Bayer HealthCare Enter into Services Agreement to Conduct Mutational Analysis
    8. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
    9. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
    10. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
    11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... -- Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company developing ... the election of Joseph J. Krivulka and ... Directors. Commenting on the election of these ... and CEO of Prismic, stated, "We are delighted that ... have accepted our invitation to join Prismic,s Board of ...
    (Date:7/1/2015)... , July 1, 2015 Dynatronics Corporation ... and marketer of rehabilitation and physical therapy products, ... private placement financing led by affiliates of Prettybrook ... investor focused on the healthcare industry. The financing ... growth and pursue potential strategic acquisitions.  ...
    (Date:7/1/2015)... SHANGHAI , July 1, 2015 Qiming ... Hu to Managing Partner effective immediately. ... He has lead and participated in many Qiming healthcare ... leaders in the Chinese market. Qiming, s success in ... and he has distinguished himself with his outstanding advocacy ...
    Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2
    ... May 8, 2012  In a little more than ... Services Organization ( CalHIPSO ) has successfully developed ... throughout California implement Electronic Health Records (EHRs), considered ... of healthcare. This and other key milestones are ...
    ... A team of scientists led by Dr. Stanley Fricke of ... "Magnetic resonance imaging (MRI) sound barrier," a finding that could ... a new clinical study published this week in the peer-reviewed ... ultimate goal," said Dr. Fricke, "is to image small children ...
    Cached Medicine Technology:CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years 2Children's National Medical Center Breaks MRI Speed Sound Barrier 2
    (Date:7/1/2015)... ... July 01, 2015 , ... In the United States, summer has ... Middle-Eastern countries like Saudi Arabia and Dubai, the summer temperatures are so hot, that ... Celebrity dentist Dr. Sam Saleh of ORA Dentistry Spa notes that a trip to ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, ... Fazle has been recognised for his outstanding contribution to enhancing the world's production and ... of the World Food Prize Foundation, announced this year’s winner at a ceremony at ...
    (Date:7/1/2015)... , ... July 01, 2015 , ... ... this land of liberty. Americans have been arguing over laws governing sexuality since ... contentious period, as a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Ormco Corporation, ... that its fifth annual Smile for a Lifetime Foundation (S4L) fundraising event held ... In addition to supporting S4L in its mission to provide free quality orthodontic ...
    (Date:7/1/2015)... ... ... Dr. Surya Challa of Chesapeake Vein Center and MedSpa in Chesapeake, VA ... discuss non-invasive CoolSculpting . On the show, Dr. Challa will explain how CoolSculpting ... utilizes Cryolipolysis to literally freeze stubborn, unwanted fat away and give patients the slim, ...
    Breaking Medicine News(10 mins):Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3
    ... Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... simultaneous webcast on Tuesday, February 3, 2009 at 8:30 ... senior management team will provide an update on the ... Information To access the live call, please dial 800-299-7098 ...
    ... Adjusted EPS Despite a Challenging Economic Environment BEDFORD, Mass., Feb. ... HOLX ), a leading developer, manufacturer and supplier of ... serving the healthcare needs of women, today announced its results ... the quarter include: , ...
    ... biopsy, a common minimally invasive biopsy method used in ... than the 14-gauge needle decreasing a physician,s chances of ... Stanford University School of Medicine in Stanford, CA. ... consecutively biopsied using a 14-gauge or 11-gauge vacuum needle. ...
    ... Finland February 02, 2009 The antiepileptic drug vigabatrin ... treatments against a special form of epilepsy in infants, called ... countries because it has been shown to cause a permanent ... who have been exposed at school age or later. A ...
    ... be given awayFORT WORTH, Texas, Feb. 2 ... Marinela USA announces the launch of the second ... January 26, 2009, Marinela USA consumers can collect ... inside specially marked boxes of Barritas Fresa, Barritas ...
    ... WASHINGTON, Feb. 2 Danaher Corporation (NYSE: ... Financial Officer, Daniel L. Comas will be presenting at ... on Monday, February 9, 2009 at 1:35 p.m. EST. ... . A replay of the webcast will be available ...
    Cached Medicine News:Health News:Rigel to Host Conference Call on February 3, 2009 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 3Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 4Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 5Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 6Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 7Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 8Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 9Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 10Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 11Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 12Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 13Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 14Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 15Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 16Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 17Health News:Controversial medication may decrease spasms for infants with epilepsy 2Health News:Marinela USA(R) Recharges ZumbAtomic for Second Season 2
    The TBS-380 Fluorometer is an economical, sensitive fluorometer designed for quick, easy, and accurate fluorescent measurements....
    ... capsular bag in cases of damaged or ... for scleral fixation with suture. Robert J. ... recognized from his early experience using the ... need for greater stability when confronted with ...
    Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
    Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
    Medicine Products: